Background and Aims: Patients with COPD exhibit persistent dys-pnea in daily activities and irreversible airflow obstruction. These will finally lead to inability to carry on daily activities and markedly decrease their quality of life. Endurance training was now considered as therapy modality to alleviate several symptoms experienced by COPD patients. The aim of this study is to identify the impact of lower-limb endurance training on dys-pnea symptom and pulmonary function test results in COPD patients. Methods: We performed experimental study in July 2017 on 20 stable COPD patients divided both in group C and D according to GOLD 2017 criteria. Patients were given individualized dose of stationary cycling twice a week for one month in which every session lasted 5-20 minutes gradually. Before and after rehabilitation program, pulmonary function tests were measured by spirometry to obtain percent predicted of FEV1, FVC, PEFR and FEF 25-75, while dyspnea scale was measured by mMRC index. Statistical analysis was performed by Wilcoxon and T-dependent test. Results: Baseline value of FVC (49.6AE21.6%) increased significantly to 59.65AE16.53% after one month of endurance training program (p=0.01). Surprisingly, there was also significant increase of FEV1 value from 46.9AE21.7 to 52.9AE20.7% (p<0.005). The increase of FVC and FEV1 in group C was slightly higher than in group D although not statistically significant (p=0.29; p=0.25 respectively). However, no difference was observed in PEFR and FEF25-75 value (p>0.05). Patients' dyspnea index also showed significant improvement (p<0.001) from mMRC median scale 2 (range 1-3) to 1 (range 0-2) in both group C and D. There was no exacerbation found during rehabilitation program. Conclusions: Twice a week lower-limb endurance training for one-month improved dyspnea scale and pulmonary function test results of COPD patients safely and effectively Background and Aims: Limb muscle wasting is one of main sys-temic manifestation of chronic obstructive pulmonary disease (COPD). However, the change of respiratory muscle is unclear. This study assessed the cross-sectional area (CSA) of the intercostal muscles (ICMs) in patients with COPD, using chest computed tomography (CT) and determined its association with the clinical characteristics of COPD. Methods: They retrospectively reviewed 60 patients with stable COPD and compared them with 30 controls. CSA (mm(2)) of the ICM on chest CT was measured at the midline level of the lateral arch of the bilateral first rib with a 3-mm slice thickness by using CT histogram software. The association with the clinical characteristics of COPD and with the control groups was assessed. Results: CSA of the ICM and the CSA/body mass index (BMI) were lower in the COPD group than in the control group. Patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 4 had a significantly lower CSA of the ICM than patients with stage 1, 2, and 3. CSA of the ICM was positively associated with FEV1 , %FEV1 predicted, FEV1 /FVC ratio, and B...